UA67368U - Фармацевтическая композиция в виде твердой дозированной лекарственной формы - Google Patents
Фармацевтическая композиция в виде твердой дозированной лекарственной формы Download PDFInfo
- Publication number
- UA67368U UA67368U UAU201115216U UAU201115216U UA67368U UA 67368 U UA67368 U UA 67368U UA U201115216 U UAU201115216 U UA U201115216U UA U201115216 U UAU201115216 U UA U201115216U UA 67368 U UA67368 U UA 67368U
- Authority
- UA
- Ukraine
- Prior art keywords
- tablet
- composition
- pharmaceutical composition
- dry
- dosage form
- Prior art date
Links
- 239000007909 solid dosage form Substances 0.000 title abstract description 3
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 abstract description 15
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 abstract description 8
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 abstract description 8
- 235000019359 magnesium stearate Nutrition 0.000 abstract description 8
- YASYEJJMZJALEJ-UHFFFAOYSA-N Citric acid monohydrate Chemical compound O.OC(=O)CC(O)(C(O)=O)CC(O)=O YASYEJJMZJALEJ-UHFFFAOYSA-N 0.000 abstract description 7
- 229960002303 citric acid monohydrate Drugs 0.000 abstract description 7
- 108010011485 Aspartame Proteins 0.000 abstract description 2
- 229940048732 althea root Drugs 0.000 abstract description 2
- 235000010357 aspartame Nutrition 0.000 abstract description 2
- 239000000605 aspartame Substances 0.000 abstract description 2
- 229960003438 aspartame Drugs 0.000 abstract description 2
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 abstract description 2
- 239000001095 magnesium carbonate Substances 0.000 abstract description 2
- 229910000021 magnesium carbonate Inorganic materials 0.000 abstract description 2
- 239000007968 orange flavor Substances 0.000 abstract description 2
- 229960001708 magnesium carbonate Drugs 0.000 abstract 1
- -1 povidon Chemical compound 0.000 abstract 1
- 239000003826 tablet Substances 0.000 description 29
- 239000000203 mixture Substances 0.000 description 21
- 239000008194 pharmaceutical composition Substances 0.000 description 18
- 239000000126 substance Substances 0.000 description 12
- 239000007910 chewable tablet Substances 0.000 description 11
- 230000001055 chewing effect Effects 0.000 description 9
- 239000004615 ingredient Substances 0.000 description 8
- 230000001225 therapeutic effect Effects 0.000 description 8
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 7
- 239000013543 active substance Substances 0.000 description 7
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 7
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 7
- 229940069328 povidone Drugs 0.000 description 7
- 206010011224 Cough Diseases 0.000 description 6
- 229940068682 chewable tablet Drugs 0.000 description 6
- 229940126601 medicinal product Drugs 0.000 description 6
- 241000183666 Nepsera aquatica Species 0.000 description 5
- 239000003814 drug Substances 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000000056 organ Anatomy 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- 230000009471 action Effects 0.000 description 4
- 210000004400 mucous membrane Anatomy 0.000 description 4
- 210000003097 mucus Anatomy 0.000 description 4
- 210000002345 respiratory system Anatomy 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 206010006451 bronchitis Diseases 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000945 filler Substances 0.000 description 3
- 150000004676 glycans Chemical class 0.000 description 3
- 239000008187 granular material Substances 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 150000004682 monohydrates Chemical class 0.000 description 3
- 229920001282 polysaccharide Polymers 0.000 description 3
- 239000005017 polysaccharide Substances 0.000 description 3
- 230000002035 prolonged effect Effects 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 2
- 244000131522 Citrus pyriformis Species 0.000 description 2
- 244000130592 Hibiscus syriacus Species 0.000 description 2
- 235000018081 Hibiscus syriacus Nutrition 0.000 description 2
- 201000008197 Laryngitis Diseases 0.000 description 2
- 239000004909 Moisturizer Substances 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000037976 chronic inflammation Diseases 0.000 description 2
- 208000037893 chronic inflammatory disorder Diseases 0.000 description 2
- 238000003745 diagnosis Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- 210000000867 larynx Anatomy 0.000 description 2
- 230000010534 mechanism of action Effects 0.000 description 2
- 230000001333 moisturizer Effects 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 208000030090 Acute Disease Diseases 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- 101100027969 Caenorhabditis elegans old-1 gene Proteins 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013952 Dysphonia Diseases 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 210000000621 bronchi Anatomy 0.000 description 1
- 210000003123 bronchiole Anatomy 0.000 description 1
- 230000001813 broncholytic effect Effects 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 210000004081 cilia Anatomy 0.000 description 1
- 229960004106 citric acid Drugs 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000029142 excretion Effects 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 210000003746 feather Anatomy 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 238000005242 forging Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000027498 hoarse voice Diseases 0.000 description 1
- 230000000544 hyperemic effect Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 235000000396 iron Nutrition 0.000 description 1
- 230000002045 lasting effect Effects 0.000 description 1
- 101150085091 lat-2 gene Proteins 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 230000000422 nocturnal effect Effects 0.000 description 1
- 238000010899 nucleation Methods 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 239000008196 pharmacological composition Substances 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 230000009747 swallowing Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Abstract
Фармацевтическая композиция в виде твердой дозированной лекарственной формы содержит алтейного корня экстракт сухой, сахар, магния карбонат легкий, аспартам, кислоты лимонной моногидрат, апельсиновый ароматизатор, повидон, магния стеарат.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201115216U UA67368U (ru) | 2011-12-22 | 2011-12-22 | Фармацевтическая композиция в виде твердой дозированной лекарственной формы |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| UAU201115216U UA67368U (ru) | 2011-12-22 | 2011-12-22 | Фармацевтическая композиция в виде твердой дозированной лекарственной формы |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA67368U true UA67368U (ru) | 2012-02-10 |
Family
ID=52288215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAU201115216U UA67368U (ru) | 2011-12-22 | 2011-12-22 | Фармацевтическая композиция в виде твердой дозированной лекарственной формы |
Country Status (1)
| Country | Link |
|---|---|
| UA (1) | UA67368U (ru) |
-
2011
- 2011-12-22 UA UAU201115216U patent/UA67368U/ru unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101919825B (zh) | 口腔吸收固体戒烟泡腾制剂 | |
| ES2314371T3 (es) | Formas de administracion aromaticas, de larga duraccion para la liberacion prolongada de sustancias activas en la boca. | |
| RU2490010C2 (ru) | Состоящая из многих частей внутриротовая лекарственная форма с органолептическими свойствами | |
| AU2012222825B2 (en) | Chewable vehicle for mouth absorption | |
| CN102198065B (zh) | 一种口腔喷雾剂及其制备方法 | |
| JP2010526876A (ja) | アミノ酸によって緩衝化されたコーティング経口ニコチン製剤 | |
| TW200927195A (en) | Sustained release dosage forms for delivery of agents to an oral cavity of a user | |
| HUE035266T2 (en) | As a buffer, a pharmaceutical product containing trometamol for oral administration of nicotine | |
| JP2013520408A (ja) | ニコチン含有ソフトゼラチントローチ | |
| Garg et al. | Medicated chewing gum: patient compliance oral drug delivery system | |
| JP2000095675A (ja) | 口中溶解型又は咀嚼型鼻炎治療用固形内服医薬組成物 | |
| KR20230007365A (ko) | 구강 또는 비강 사용을 위한 신규 조성물 | |
| CN101904827A (zh) | 盐酸氨溴索口腔崩解片及其制备方法 | |
| CN100584341C (zh) | 动物类中药配方颗粒腥臭味的掩盖方法 | |
| KR20220164725A (ko) | 구강 또는 비강 사용을 위한 신규 조성물 | |
| CN109453169B (zh) | 草乌甲素的用途 | |
| CN101401796A (zh) | 普拉克索口腔崩解片及其制备方法 | |
| CN1327862C (zh) | 复方甘草***片及其制备方法 | |
| CN102552247B (zh) | 一种维生素c的组合物及其制备方法 | |
| JPH0426618A (ja) | トローチ剤 | |
| KR101401628B1 (ko) | 간기능 개선용 정제 및 그 제조 방법 | |
| CN102210453A (zh) | 泡腾口香糖及其制备方法 | |
| TWI343818B (ru) | ||
| JP7492772B2 (ja) | 咽頭反射の処置のための組成物および治療 | |
| KR100381622B1 (ko) | 자극성을 줄인 염기성 약물의 구강 투여 조성물 |